Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 4—April 2022
Research Letter

Time from Exposure to Diagnosis among Quarantined Close Contacts of SARS-CoV-2 Omicron Variant Index Case-Patients, South Korea

Author affiliations: Korea Disease Control and Prevention Agency, Cheongju, South Korea (H.R. Lee, E.J. Jang, J. Kim, J.J. Lee, H.Y. Lee, H. Park, S.E. Lee, Y.-J. Park); Korea University Anam Hospital, Seoul, South Korea (Y.J. Choe); Incheon Metropolitan City, Incheon, South Korea (M. Kim, S. Kim, H. Yoo); Jeollabuk-do Center for Infectious Disease Control and Prevention, Jeonju, South Korea (J.-H. Lee); Jeollabuk-do Government, Jeonju (H.J. Ahn, M.-Y. Go); Jeollanam-do Government, Muan, South Korea (W.I. Kim, B.S. Lee); Gwangju Metropolitan Government, Gwangju, South Korea (H.-P. Ko); Honam Reginal Center for Disease Control and Prevention, Gwangju (J. Yu, E.-Y. Kim, H. Jeong, J.-H. Chung); Capital Regional Center for Disease Control and Prevention, Seoul (J.S. Song, J. Lee, M.Y. Kim)

Cite This Article

Abstract

To determine optimal quarantine duration, we evaluated time from exposure to diagnosis for 107 close contacts of severe acute respiratory syndrome coronavirus 2 Omicron variant case-patients. Average time from exposure to diagnosis was 3.7 days; 70% of diagnoses were made on day 5 and 99.1% by day 10, suggesting 10-day quarantine.

Since its identification in November 2021, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern has rapidly spread across the globe (1). In South Korea, the first case-patient infected with the Omicron variant was identified on November 24, 2021, among inbound international travelers (2). In response, all close contacts of Omicron case-patients were required to quarantine for 14 days, regardless of vaccination and symptom status (3). Prolonged quarantine of close contacts of persons infected with newly emerging pathogens may pose a substantial burden on society. To determine optimal quarantine duration, we quantified time from exposure to diagnosis among close contacts of SARS-CoV-2 Omicron index case-patients. The study was conducted as a legally mandated public health investigation under the authority of government activity.

The study population consisted of close contacts of 2 clusters of SARS-CoV-2 Omicron case-patients detected on November 24 and 25, 2021. All quarantined close contacts were actively monitored by public health officers and were tested with reverse transcription PCR on days 1, 9, and 13 (4). We retrieved demographic information from the epidemiologic investigation form. Coronavirus disease (COVID-19) vaccination status was verified through documentation. Presence of fever or worsening or onset of symptoms was assessed daily, and persons were tested when deemed necessary. We calculated the time from exposure to the index case-patient and diagnosis of SARS-CoV-2 for close contacts in days (mean, median, interquartile range). We used the inverse Kaplan-Meier curve to visualize the percentage of diagnoses in a given interval.

Figure

Cumulative events by time from exposure to index case-patients infected with severe acute respiratory syndrome coronavirus 2 Omicron variant of concern to diagnosis of infection, South Korea. A) Total cases; B) by age group; C) by vaccination status; and D) by symptom status.

Figure. Cumulative events by time from exposure to index case-patients infected with severe acute respiratory syndrome coronavirus 2 Omicron variant of concern to diagnosis of infection, South Korea. A) Total cases;...

We identified 107 close contacts of SARS-CoV-2 Omicron index case-patients, and the average time from exposure to diagnosis (± SD) was 3.7 (± 2.6) days (Table; Figure). We [[ANCHOR###F1######Anchor]]calculated the cumulative cases by time from exposure to diagnosis for total cases according to age group, according to vaccination status, and according to symptom status. Among all case-patients, diagnoses were made for 50% on day 3, and for 70% on day 5 (Figure, panel A). By day 10, almost all (106 [99.1%]) diagnoses had been made; 1 diagnosis was made on day 13 for an unvaccinated child with a previous negative test result. For all age groups (Figure, panel B), diagnoses were made for 50% on day 3; among those >20 years of age, for 70% on day 4; and among those <20 years of age, on day 5 (p = 0.051). Among close contacts who were symptomatic on the day of encounter, diagnoses were made for 50% on day 3 and 70% on day 5. Among asymptomatic close contacts, diagnoses were made for 50% on day 5 and 70% on day 8 (p = 0.001) (Figure, panel D).

We found that most (99.1%) diagnoses for the close contacts of the Omicron index case-patients were made within 10 days of quarantine; mean interval varied according to symptom status. Supported by this finding, the quarantine duration in South Korea was shortened from 14 to 10 days for all case-patients and even shorter (to 7 days) if quarantine facilities were at capacity because of a surge of cases (3).

Among the limitations of our study, individual public health officers decided to test on days 2–8 and 10–12; therefore, the chance of being tested on any day may have differed for each close contact. Nonetheless, early testing may have been driven by the presence of symptoms and influenced by an individual close contact’s desire to get tested, which may have affected the decision of public health officers. Moreover, because tests were not performed after day 13, we do not have information on long incubation periods. Given that the study population was from 2 distinctive clusters, incubation periods may differ according to characteristics of illness in the index case-patients, which may affect study results. Despite these limitations, were able to quantify the time from exposure to diagnosis and estimate the optimal duration of quarantine for persons exposed to Omicron.

Implementing quarantine early in a pandemic is crucial for slowing the spread of a novel pathogen (5). Previous studies have suggested that the incubation period for Omicron could be shorter than that for the SARS-CoV-2 Delta variant (J. Chen, unpub. data, https://arxiv.org/abs/2112.01318). Estimating the duration of infectiousness is more challenging than measuring incubation periods; one study that measured viral load of Omicron suggested that viral load had diminished by days 10–13, which is in line with our findings (6).

To mitigate spread of highly contagious pathogens, the most effective public health measures are isolation and quarantine; however, these measures inevitably lead to personal and socioeconomic costs, necessitating evidence-based guidance from policy makers. A 10-day quarantine period may encompass most persons exposed to Omicron; however, quarantine duration may become shorter after balancing societal cost with public health benefit.

Mrs. H.R. Lee is a public health officer at Korea Disease Control and Prevention Agency. Her main research interest is epidemiologic investigation and surveillance measures of infectious diseases. Dr. Choe is a clinical assistant professor of pediatrics at Korea University Anam Hospital. His main research addresses quantification of and understanding the mechanisms of the effects of immunization programs on public health.

Top

Acknowledgments

We thank the relevant ministries, including the Ministry of Interior and Safety, Si/Do and Si/Gun/Gu, medical staff in health centers, and medical facilities for their efforts in responding to the COVID-19 pandemic.

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the Korea Disease Control and Prevention Agency or the institutions with which the authors are affiliated.

Top

References

  1. Meo  SA, Meo  AS, Al-Jassir  FF, Klonoff  DC. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. Eur Rev Med Pharmacol Sci. 2021;25:80128.PubMedGoogle Scholar
  2. Lee  JJ, Choe  YJ, Jeong  H, Kim  M, Kim  S, Yoo  H, et al. Importation and transmission of SARS-CoV-2 B.1.1.529 (Omicron) variant of concern in Korea, November 2021. J Korean Med Sci. 2021;36:e346. DOIPubMedGoogle Scholar
  3. Petersen  E, Ntoumi  F, Hui  DS, Abubakar  A, Kramer  LD, Obiero  C, et al. Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa’s research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis. 2022;114:26872. DOIPubMedGoogle Scholar
  4. Quarantine Management Team, COVID-19 National Emergency Response Center. Coronavirus disease-19: quarantine framework for travelers entering Korea. Osong Public Health Res Perspect. 2020;11:1339. DOIPubMedGoogle Scholar
  5. Nussbaumer-Streit  B, Mayr  V, Dobrescu  AI, Chapman  A, Persad  E, Klerings  I, et al. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev. 2020;4:CD013574.
  6. National Institute of Infectious Diseases Disease Control and Prevention Center, National Center for Global Health and Medicine. Active epidemiological investigation on SARS-CoV-2 infection caused by Omicron variant (Pango lineage B.1.1.529) in Japan: preliminary report on infectious period [cited 2022 Jan 15]. https://www.niid.go.jp/niid/en/2019-ncov-e/10884-covid19-66-en.html

Top

Figure
Table

Top

Cite This Article

DOI: 10.3201/eid2804.220153

Original Publication Date: March 11, 2022

1These authors contributed equally to this article.

Table of Contents – Volume 28, Number 4—April 2022

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Young-Joon Park, Director of Epidemiologic Investigation, (28159) Korea Disease Control and Prevention Agency, Osong Health Technology Administration Complex, 187, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea

Send To

10000 character(s) remaining.

Top

Page created: February 06, 2022
Page updated: March 19, 2022
Page reviewed: March 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external